In these states, beneficiaries have access to Wegovy, Zepbound, and Saxenda, alongside Type 2 diabetes-indicated options such as Ozempic, Mounjaro, and Rybelsus
Adesanya AW, Morales MA, Walsh DB, Lavine LC, Lavine MD, Zhu F
Off-Label Options Gabapentin Lower NNT of 8 for preventing return to heavy drinking [22] Not FDA-approved for AUD Limited long-term safety data Potentially associated with cases of abuse and overdose [23, 24] Less ideal for ED initiation due to abuse liability GLP-1 Agonists An area of recent interest has been on the potential use of GLP-1 agonists, such as semaglutide and liraglutide , for the treatment of AUD
Some clinicians extend each phase to 68 weeks instead of 4, which makes practical sense for tolerability and accurately assessing ones true minimum effective dose
Patients on consistent Sermorelin therapy generally see effects in a similar window to other GH-pathway peptides, with the caveat that the effect magnitude tends to be smaller